Mosaic loss of Chromosome Y in aged human microglia

Michael C Vermeulen1, Richard Pearse2, Tracy Young-Pearse2

  • 1Center for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.

Genome Research
|August 30, 2022
PubMed

Insights

Mosaic loss of chromosome Y (LOY) is common in aging men and linked to diseases like Alzheimer's. This study found LOY is significantly enriched in microglia within the brain, especially in Alzheimer's patients.

Area of Science:

  • Genetics
  • Neuroscience
  • Immunology

Background:

  • Mosaic loss of chromosome Y (LOY) is a common acquired mutation in aging men's leukocytes.
  • LOY is correlated with age-related diseases, including Alzheimer's disease (AD).
  • The molecular basis and cell-type specificity of LOY in the brain remain largely uninvestigated.

Purpose of the Study:

  • To investigate the cell type-specific burden of mosaic loss of chromosome Y (LOY) in the human brain.
  • To determine the association of LOY with Alzheimer's disease (AD) at a single-cell level.
  • To identify genes associated with LOY in specific brain cell types.

Main Methods:

  • Analysis of a large-scale dataset comprising 851,674 single-cell and single-nuclei RNA sequencing data from human brain samples.
  • Comparative analysis of LOY frequencies across different central nervous system (CNS) cell types.
  • Differential gene expression (DE) analysis in LOY-enriched cell populations.

Main Results:

  • LOY frequencies varied significantly between individuals and CNS cell types.
  • LOY was found to be enriched in microglia and rare in neurons, astrocytes, and oligodendrocytes.
  • In microglia, LOY was significantly enriched in subjects with Alzheimer's disease (AD), with associated differential expression of autosomal, X-linked, and pseudoautosomal genes.

Conclusions:

  • This study provides the first evidence of mosaic loss of chromosome Y (LOY) in human brain microglia.
  • The findings highlight the potential role of LOY in microglial function during aging and neurodegeneration, particularly in Alzheimer's disease (AD).
  • LOY in microglia may represent a novel molecular mechanism contributing to the pathogenesis of neurodegenerative disorders.

Related Concept Videos